0001209191-22-003195.txt : 20220113 0001209191-22-003195.hdr.sgml : 20220113 20220113163602 ACCESSION NUMBER: 0001209191-22-003195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220111 FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sofinnova Partners SAS CENTRAL INDEX KEY: 0001574139 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41201 FILM NUMBER: 22529419 BUSINESS ADDRESS: STREET 1: 17 RUE DE SERENE CITY: PARIS STATE: I0 ZIP: 75008 BUSINESS PHONE: 33 1 53 05 41 13 MAIL ADDRESS: STREET 1: 17 RUE DE SERENE CITY: PARIS STATE: I0 ZIP: 75008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sofinnova Capital IX CENTRAL INDEX KEY: 0001849915 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41201 FILM NUMBER: 22529418 BUSINESS ADDRESS: STREET 1: 7-11 BOULEVARD HAUSSMANN CITY: PARIS STATE: I0 ZIP: 75009 BUSINESS PHONE: 33(0)1 76 23 41 00 MAIL ADDRESS: STREET 1: 7-11 BOULEVARD HAUSSMANN CITY: PARIS STATE: I0 ZIP: 75009 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CinCor Pharma, Inc. CENTRAL INDEX KEY: 0001868734 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 8445311834 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-11 0 0001868734 CinCor Pharma, Inc. CINC 0001574139 Sofinnova Partners SAS 7-11 BOULEVARD HAUSSMANN PARIS I0 75009 FRANCE 0 0 1 0 0001849915 Sofinnova Capital IX 7-11 BOULEVARD HAUSSMANN PARIS I0 75009 FRANCE 0 0 1 0 Common Stock 2022-01-11 4 C 0 3867646 A 3867646 I By Sofinnova Capital IX Common Stock 2022-01-11 4 P 0 220000 16.00 A 4087646 I By Sofinnova Capital IX Series A Preferred Stock 2022-01-11 4 C 0 9999999 0.00 D Common Stock 2941176 0 I By Sofinnova Capital IX Series B Preferred Stock 2022-01-11 4 C 0 3150000 0.00 D Common Stock 926470 0 I By Sofinnova Capital IX Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date. The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein. Sofinnova Partners SAS, By /s/ Monique Saulnier, Managing Partner 2022-01-13 Sofinnova Capital IX, By: Sofinnova Partners SAS, its management company, By /s/ Monique Saulnier, Managing Partner 2022-01-13